Table 2.
Clinical findings in EC
| Finding | N |
|---|---|
| Haematuria (gross, microscopic)2 4 7 9–21 23 24 27 32–35 | 28 (50%) |
| Bladder mass/velvety lesions2 4 7 9 10 13 15 16 18 20 23 28 29 33 35 36 | 27 (48%) |
| Peripheral eosinophilia4 7 9 11 12 15 16 18 20 22 25–27 31 33 34 | 21 (38%) |
| Thickened bladder wall2 4 7 9 10 13 15 16 18 20 23 28 29 33 35 36 | 21 (38%) |
| Haemorrhagic lesions/erythema/ulcers/erythematous plaques8 10 14 19 20 24 27 32 34 36 | 16 (29%) |
| Oedema/inflammation of the bladder mucosa2 4 9 11 12 14 17–20 25 27 34 | 15 (27%) |
| Hydronephrosis/hydroureteronephrosis2 4 11 15 16 29 32 33 | 11 (20%) |
| Pyuria4 9 11 12 16 18 23 28 34 | 10 (18%) |
| Positive urine culture4 11 13 16 18 20 32 | 9 (16%) |
| Reduced bladder capacity/compliance4 25 28 | 3 (5%) |
| Vesicoureteral reflux4 17 29 | 3 (5%) |
| Inflammation of the ureter/pelvis/ureteral orifice17 31 | 2 (4%) |
| Paracytosis8 32 | 2 (4%) |
| Stenosis of the ureteral orifice29 | 1 (2%) |
| Bladder neck contracture13 | 1 (2%) |
| Abdominal distention (free fluid in abdomen)30 | 1 (2%) |